BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 1365682)

  • 1. Ten-year follow-up of breast carcinoma in situ in Connecticut.
    Ward BA; McKhann CF; Ravikumar TS
    Arch Surg; 1992 Dec; 127(12):1392-5. PubMed ID: 1365682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ductal carcinoma in situ of the breast].
    Rueda Domínguez A; Alonso Muñoz MC; Gómez Gómez A; Ojeda González B
    Med Clin (Barc); 1993 Oct; 101(14):548-56. PubMed ID: 8231402
    [No Abstract]   [Full Text] [Related]  

  • 3. Current management of ductal carcinoma in situ.
    Barth A; Brenner RJ; Giuliano AE
    West J Med; 1995 Oct; 163(4):360-6. PubMed ID: 7483593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcinoma in situ. Prognostic factors].
    Trojani M
    Arch Anat Cytol Pathol; 1994; 42(5):234-50. PubMed ID: 7872815
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pathologic Finding of Combined Lobular Carcinoma
    Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
    Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction mammaplasty specimens and occult breast carcinomas.
    Kakagia D; Fragia K; Grekou A; Tsoutsos D
    Eur J Surg Oncol; 2005 Feb; 31(1):19-21. PubMed ID: 15642421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age.
    Evans WP; Starr AL; Bennos ES
    Radiology; 1997 Aug; 204(2):489-91. PubMed ID: 9240541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of lobular carcinoma in situ and ductal carcinoma in situ of the breast.
    Wood WC
    Semin Oncol; 1996 Aug; 23(4):446-52. PubMed ID: 8757271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004.
    Eheman CR; Shaw KM; Ryerson AB; Miller JW; Ajani UA; White MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1763-9. PubMed ID: 19454615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ.
    Downs-Kelly E; Bell D; Perkins GH; Sneige N; Middleton LP
    Arch Pathol Lab Med; 2011 Jun; 135(6):737-43. PubMed ID: 21631266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
    Luke C; Priest K; Roder D
    Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in incidence and management of lobular carcinoma in situ: a population-based analysis.
    Portschy PR; Marmor S; Nzara R; Virnig BA; Tuttle TM
    Ann Surg Oncol; 2013 Oct; 20(10):3240-6. PubMed ID: 23846782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for women with lobular carcinoma in situ (LCIS).
    Oppong BA; King TA
    Oncology (Williston Park); 2011 Oct; 25(11):1051-6, 1058. PubMed ID: 22106556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An epidemiologic study of differences between mammary ductal and lobular carcinoma in situ: analysis of 11,436 cases from the California Cancer Registry.
    Saltzstein SL
    Anat Pathol; 1996; 1():193-203. PubMed ID: 9390929
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ductal carcinoma in situ of the breast].
    Barth A; Köchli OR; Brenner RJ; Giuliano E; Castiglione M
    Schweiz Med Wochenschr; 1995 Jan; 125(4):103-12. PubMed ID: 7878398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lobular carcinoma in situ of the breast].
    Llanos Muñoz M; Alonso Muñoz MC; Ojeda González B
    Med Clin (Barc); 1994 Oct; 103(14):553-6. PubMed ID: 7799670
    [No Abstract]   [Full Text] [Related]  

  • 18. Local recurrence after ductal carcinoma in situ breast conserving treatment. Analysis of 195 cases.
    Cutuli B; Lemanski C; Le Blanc-Onfroy M; de Lafontan B; Cohen-Solal-Le-Nir C; Fondrinier E; Mignotte H; Giard S; Charra-Brunaud C; Auvray H; Gonzague-Casabianca L; Quétin P; Fay R
    Cancer Radiother; 2013 Jun; 17(3):196-201. PubMed ID: 23538041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobular carcinoma in situ (LCIS) of the breast: is long-term outcome similar to ductal carcinoma in situ (DCIS)? Analysis of 200 cases.
    Cutuli B; De Lafontan B; Kirova Y; Auvray H; Tallet A; Avigdor S; Brunaud C; Delva C
    Radiat Oncol; 2015 May; 10():110. PubMed ID: 25944033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ductal carcinoma in situ of the breast in younger women: a subgroup of patients at high risk.
    Tunon-de-Lara C; Lemanski C; Cohen-Solal-Le-Nir C; de Lafontan B; Charra-Brunaud C; Gonzague-Casabianca L; Mignotte H; Fondrinier E; Giard S; Quetin P; Auvray H; Cutuli B
    Eur J Surg Oncol; 2010 Dec; 36(12):1165-71. PubMed ID: 20889280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.